Masimo Corp
MASI145.720USD
-1.720-1.17%
Cierre 09/15, 16:00（ET）Cotizaciones retrasadas 15 min
7.91BCap. mercado
PérdidaP/E TTM
Más Datos de Masimo Corp Compañía
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.
Información de la empresa
Símbolo de cotizaciónMASI
Nombre de la empresaMasimo Corp
Fecha de salida a bolsaAug 08, 2007
Director ejecutivoMs. Catherine M. (Katie) Szyman
Número de empleados3600
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 08
Dirección52 Discovery
CiudadIRVINE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal92618
Teléfono19492977000
Sitio Webhttps://www.masimo.com/
Símbolo de cotizaciónMASI
Fecha de salida a bolsaAug 08, 2007
Director ejecutivoMs. Catherine M. (Katie) Szyman
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
8.61K
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Catherine M. (Katie) Szyman
Ms. Catherine M. (Katie) Szyman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy E. Lane
Ms. Wendy E. Lane
Independent Director
Independent Director
--
--
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Director
Independent Director
--
--
Ms. Michelle M. Brennan
Ms. Michelle M. Brennan
Chairman of the Board
Chairman of the Board
--
--
Ms. Lisa Hellmann
Ms. Lisa Hellmann
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
8.61K
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Catherine M. (Katie) Szyman
Ms. Catherine M. (Katie) Szyman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2024
FY2023
FY2022
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.13B
53.84%
Europe, Middle East and Africa
595.60M
28.44%
Asia and Australia
303.50M
14.49%
North and South America (excluding the U.S.)
67.70M
3.23%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: dom., 17 de ago
Actualizado: dom., 17 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.78%
The Vanguard Group, Inc.
8.52%
Politan Capital Management, L.P.
8.45%
BlackRock Institutional Trust Company, N.A.
7.80%
BlackRock Investment Management (UK) Ltd.
5.66%
Otro
56.79%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.78%
The Vanguard Group, Inc.
8.52%
Politan Capital Management, L.P.
8.45%
BlackRock Institutional Trust Company, N.A.
7.80%
BlackRock Investment Management (UK) Ltd.
5.66%
Otro
56.79%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
53.31%
Investment Advisor/Hedge Fund
31.50%
Hedge Fund
16.60%
Individual Investor
5.97%
Research Firm
2.62%
Bank and Trust
1.67%
Pension Fund
1.15%
Venture Capital
0.21%
Sovereign Wealth Fund
0.17%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
937
59.97M
110.39%
-7.53M
2025Q1
981
59.62M
109.96%
-8.22M
2024Q4
950
56.99M
105.70%
-7.11M
2024Q3
945
55.24M
103.11%
-8.43M
2024Q2
962
54.27M
102.01%
-12.67M
2024Q1
1002
56.30M
106.05%
-9.64M
2023Q4
1090
55.26M
104.56%
-6.33M
2023Q3
1093
52.14M
98.67%
-6.57M
2023Q2
1090
50.54M
95.73%
-6.92M
2023Q1
1117
49.67M
94.09%
-7.79M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
6.93M
12.79%
+25.96K
+0.38%
Mar 31, 2025
The Vanguard Group, Inc.
4.57M
8.43%
-3.43K
-0.07%
Mar 31, 2025
Politan Capital Management, L.P.
4.72M
8.73%
+1.79K
+0.04%
Apr 29, 2025
BlackRock Institutional Trust Company, N.A.
4.13M
7.62%
-1.41M
-25.40%
Mar 31, 2025
BlackRock Investment Management (UK) Ltd.
2.73M
5.04%
+1.17M
+74.98%
Mar 31, 2025
Kiani (Joe E)
4.11M
7.57%
-75.75K
-1.81%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.67M
3.09%
+10.88K
+0.65%
Mar 31, 2025
MFS Investment Management
1.96M
3.62%
+231.45K
+13.36%
Mar 31, 2025
Capital Research Global Investors
2.06M
3.79%
-398.88K
-16.25%
Mar 31, 2025
BlackRock Financial Management, Inc.
1.74M
3.21%
-207.54K
-10.65%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de sep
Actualizado: sáb., 6 de sep
Nombre
Proporción
First Trust Indxx Medical Devices ETF
1.74%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.68%
Hypatia Women CEO ETF
0.51%
Invesco NASDAQ Future Gen 200 ETF
0.38%
ProShares UltraPro MidCap400
0.23%
Strive Mid-Cap ETF
0.22%
SoFi Next 500 ETF
0.13%
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
0.04%
Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF
0.03%
SPDR Russell 1000 Momentum Focus ETF
0.02%
Ver más
First Trust Indxx Medical Devices ETF
Proporción1.74%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción1.68%
Hypatia Women CEO ETF
Proporción0.51%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.38%
ProShares UltraPro MidCap400
Proporción0.23%
Strive Mid-Cap ETF
Proporción0.22%
SoFi Next 500 ETF
Proporción0.13%
PIMCO RAFI Dynamic Multi-Factor US Equity ETF
Proporción0.04%
Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF
Proporción0.03%
SPDR Russell 1000 Momentum Focus ETF
Proporción0.02%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
